HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19.

Abstract
This study investigated associations between chest computed tomography (CT) pulmonary opacity score on admission and clinical features and outcomes in COVID-19 patients. The retrospective multi-center cohort study included 496 COVID-19 patients in Jiangsu province, China diagnosed as of March 15, 2020. Patients were divided into four groups based on the quartile of pulmonary opacity score: ≤ 5%, 6-20%, 21-40% and 41% +. CT pulmonary opacity score was independently associated with age, single onset, fever, cough, peripheral capillary oxygen saturation, lymphocyte count, platelet count, albumin level, C-reactive protein (CRP) level and fibrinogen level on admission. Patients with score ≥ 41% had a dramatic increased risk of severe or critical illness [odds ratio (OR), 15.58, 95% confidence interval (CI) 3.82-63.53), intensive care unit (ICU)] admission (OR, 6.26, 95% CI 2.15-18.23), respiratory failure (OR, 19.49, 95% CI 4.55-83.40), and a prolonged hospital stay (coefficient, 2.59, 95% CI 0.46-4.72) compared to those with score ≤ 5%. CT pulmonary opacity score on admission, especially when ≥ 41%, was closely related to some clinical characteristics and was an independent predictor of disease severity, ICU admission, respiratory failure and long hospital stay in patients with COVID-19.
AuthorsHuanyuan Luo, Yuancheng Wang, Songqiao Liu, Ruoling Chen, Tao Chen, Yi Yang, Duolao Wang, Shenghong Ju
JournalInternal and emergency medicine (Intern Emerg Med) Vol. 17 Issue 1 Pg. 153-163 (01 2022) ISSN: 1970-9366 [Electronic] Italy
PMID34191219 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021. Società Italiana di Medicina Interna (SIMI).
Topics
  • COVID-19
  • Cohort Studies
  • Humans
  • Retrospective Studies
  • SARS-CoV-2
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: